Public health approach to emerging infections among pregnant women

American Journal of Public Health

Volumn 95, Issue 11, 2005, Pages 1942-1944

  Rasmussen, Sonja A ^a,c   Hayes, Edward B ^b  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE SEVERITY; EMBRYO; FEMALE; FETUS; FETUS RISK; HUMAN; INFECTION; INFECTION PREVENTION; INFECTION RISK; INFECTION SENSITIVITY; INFLUENZA; MATERNAL MORBIDITY; MATERNAL MORTALITY; PREGNANT WOMAN; PROGENY; RISK FACTOR; VERTICAL TRANSMISSION;

ANTI-INFECTIVE AGENTS; FEMALE; HUMANS; IMMUNIZATION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PUBLIC HEALTH PRACTICE; UNITED STATES;

EID: 27644461048     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.2004.054957     Document Type: Article

References (37)

1. Hayes EB, O'Leary DR. West Nile virus infection: a pediatric perspective. Pediatrics. 2004;113:1375-1381.
2. Svoboda T, Henry B, Shulman L, et al. Public health measures to control the spread of the severe acute respiratory syndrome during the outbreak in Toronto. N Engla J Med. 2004;350:2352-2361.
3. Reed KD, Melski JW, Graham MB, et al. The detection of monkeypox in humans in the Western Hemisphere. N Engl J Med. 2004;350:342-350.
4. Inglesby TV, O'Toole T, Henderson DA, et al. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA. 2002;287:2236-2252.
5. Webby RJ, Webster RG. Are we ready for pandemic influenza? Science. 2003;302:1519-1522.
6. Mortimer PP. Anticipating smallpox as a bioterrorist weapon. Clin Med 2003;3:255-259.
7. Centers for Disease Control and Prevention. Preventing emerging infectious diseases: A strategy for the 21st century. Overview of the updated CDC plan. MMWR Recomm Rep. 1998;47:1-14.
8. Emerging Infectious Diseases Journal website. Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/ncidod/eid/about/background. htm. Accessed November 27, 2004.
9. Emerging Infectious Diseases: Addressing the Problem of Diseases of Pregnant Women and Newborns. Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/ncidod/emergplan/pregnant_and_newbornes/ pregnant_and_newborn.pdf. Accessed December 5, 2004.
10. Wong SF, Chow KM, Leung TN, et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol. 2004;191:292-297.
11. Stockman LJ, Lowther SA, Coy K, Saw J, Parashar UD. SARS during pregnancy, United States. Emerg Infect Dis. 2004;10:1689-1690.
12. Centers for Disease Control and Prevention. Interim guidelines for the evaluation of infants born to mothers infected with West Nile virus during pregnancy. MMWR Morb Mortal Wkly Rep. 2004;53:154-157.
13. Centers for Disease Control and Prevention. Intrauterine West Nile virus infection-New York, 2002. MMWR Morb Mortal Wkly Rep. 2002;51:1135-1136.
14. Kadanali A, Tasyaran MA, Kadanali S. Anthrax during pregnancy: case reports and review. Clin Infect Dis. 2003;36:1343-1346.
15. Okoko BJ, Enwere G, Ota MO. The epidemiology and consequences of maternal malaria: a review of immunological basis. Acta Trop. 2003;87:193-205.
16. Avelino MM, Campos D, Jr., do Carmo Barbosa de Parada J, de Castro AM. Pregnancy as a risk factor for acute toxoplasmosis seroconversion. Eur J Obstet Gynecol Reprod Biol. 2003;108:19-24.
17. Lyde CB. Pregnancy in patients with Hansen disease. Arch Dermatol. 1997;133:623-627.
18. Snider D. Pregnancy and tuberculosis. Chest. 1984;86:10S-13S.
19. Harris JW. Influenza occurring in pregnant women. JAMA. 1919;14:978-980.
20. Freeman DW, Barno A. Deaths from Asian influenza associated with pregnancy. Am J Obstet Gynecol. 1959;78:1172-1175.
21. Neuzil KM, Reed GW, Mitchel EF, Simonsen L, Griffin MR. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol. 1998;148:1094-1102.
22. Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2004;53:1-40.
23. Lam CM, Wong SF, Leung TN, et al. A case-controlled study comparing clinical course and outcomes of pregnant and nonpregnant women with severe acute respiratory syndrome. Bjog. 2004;111:771-774.
24. Jongen VH, van Roosmalen J, Tiems J, Van Holten J, Wetsteyn JC. Tick-borne relapsing fever and pregnancy outcome in rural Tanzania. Acta Obstet Gynecol Scand. 1997;76:834-838.
25. Bale JF, Jr. Congenital infections. Neurol Clin. 2002;20:1039-1060.
26. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1997;46:1-25.
27. Rutstein RM. Prevention of perinatal HIV infection. Curr Opin Pediatr. 2001;13:408-416.
28. Centers for Disease Control and Prevention. Supplemental recommendations on adverse events following smallpox vaccine in the pre-event vaccination program: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2003;52:282-284.
29. Lo WY, Friedman JM. Teratogenicity of recently introduced medications in human pregnancy. Obstet Gynecol. 2002;100:465-473.
30. Centers for Disease Control and Prevention. Updated recommendations for antimicrobial prophylaxis among asymptomatic pregnant women after exposure to Bacillus anthracis. MMWR Morb Mortal Wkly Rep. 2001;50:960.
31. Management of asymptomatic pregnant or lactating women exposed to anthrax. Int J Gynaecol Obstet. 2002;77:293-295.
32. Miller E, Cradock-Watson JE, Pollock TM. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet. 1982;2:781-784.
33. Stagno S, Whitley RJ. Herpesvirus infections of pregnancy. Part I: Cytomegalovirus and Epstein-Barr virus infections. N Engl J Med. 1985;313:1270-1274.
34. Lewis DB, Wilson CB. Developmental immunology and role of host defenses in fetal and neonatal susceptibility to infection. In: Remington JS, Klein JO, eds. Infectious Diseases of the Fetus and Newborn Infant. 5th ed. Philadelphia: WB. Saunders Company; 2001:25-138.
35. Alford CA. Immunoglobulin determinations in the diagnosis of fetal infection. Pediatr Clin North Am. 1971;18:99-113.
36. Pinon JM, Dumon H, Chemla C, et al. Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J Clin Microbiol. 2001;39:2267-2271.
37. Alford CA, Foft JW, Blankenship WJ, Cassady G, Benton JW. Subclinical central nervous system disease of neonates: A prospective study of infants born with increased levels of IgM. J Pediatr. 1969;75:1167-1178.